MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

MDT

88.16

-0.5%↓

A

115.44

-1.15%↓

VEEV

157.4

-5.83%↓

HQY

83.69

+2.27%↑

TLRY

6.71

-0.59%↓

Search

Quanterix Corp

Deschisă

SectorSănătate

3.3 -7.56

Rezumat

Modificarea prețului

24h

Curent

Minim

3.26

Maxim

3.57

Indicatori cheie

By Trading Economics

Venit

10M

-23M

Vânzări

3.7M

44M

Marjă de profit

-52.712

Angajați

450

EBITDA

15M

-17M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+114.29% upside

Dividende

By Dow Jones

Următoarele câștiguri

11 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-127M

169M

Deschiderea anterioară

10.86

Închiderea anterioară

3.3

Sentimentul știrilor

By Acuity

50%

50%

168 / 349 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

8 apr. 2026, 20:44 UTC

Câștiguri

Costco Reports 11% Growth in March Sales

8 apr. 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 apr. 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 apr. 2026, 23:36 UTC

Market Talk
Evenimente importante

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 apr. 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 apr. 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 apr. 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 apr. 2026, 21:52 UTC

Evenimente importante

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 apr. 2026, 21:24 UTC

Câștiguri

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 apr. 2026, 21:01 UTC

Evenimente importante

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 apr. 2026, 20:43 UTC

Achiziții, Fuziuni, Preluări

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 apr. 2026, 20:42 UTC

Achiziții, Fuziuni, Preluări

Oracle Responds to TRC Cap Mini-Tender Offer

8 apr. 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 apr. 2026, 20:11 UTC

Achiziții, Fuziuni, Preluări

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 apr. 2026, 19:44 UTC

Câștiguri

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 apr. 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8 apr. 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8 apr. 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 apr. 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 apr. 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 apr. 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 apr. 2026, 18:14 UTC

Evenimente importante

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 apr. 2026, 18:05 UTC

Evenimente importante

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

114.29% sus

Prognoză pe 12 luni

Medie 7.5 USD  114.29%

Maxim 8 USD

Minim 7 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

168 / 349 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat